LESLIE KELLAM: Open Payments
NPI 1699445056 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 4 payments from 4 companies in 2025. Trend: 2023 $660 · 2024 $475 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Genentech USA, Inc. | 1 | $122 |
| Madrigal Pharmaceuticals | 1 | $111 |
Products named: Wegovy, REXULTI, Xolair, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
